J&J | GenomeWeb

J&J

The companies will work to develop an affordable, portable, and easy-to-use HIV quantitative viral load test using Cue's Lab-In-A-Box MDx platform.

Johnson & Johnson announced that it would be cutting about 3,000 jobs from its medical devices section.

Using J&J's CellSearch platform, researchers have demonstrated the expression of PD-L1 on CTCs, a finding they believe they are the first to show.

Three new assays were presented in posters at April's Clinical Virology Symposium.

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

NEW YORK (GenomeWeb News) – Janssen Biotech and Johnson & Johnson Innovation today announced a research alliance with the Icahn School of Medicine at Mount Sinai to advance a better understanding of inflammatory bowel disease.

A new firm threw its hat into the RNAi therapeutics ring this week, with San Diego startup Arcturus Therapeutics announcing that it has raised $1.3 million in seed financing to advance proprietary siRNA delivery and formulation technologies into in vivo proof-of-concept

NEW YORK (GenomeWeb News) – Microbiome company Second Genome today announced a deal with Johnson & Johnson's Janssen Biotech aimed at microbiome drug discovery.
Second Genome also announced it raised an additional $6.5 million in Series A financing.

A group of Australian researchers has identified a set of plasma proteins that could help predict patient levels of the Alzheimer's disease-associated molecule beta-amyloid.

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research said today that it will collaborate with Johnson & Johnson company Janssen to conduct clinical trials aimed at identifying new prostate cancer biomarkers.

Pages

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.